Senior Therapeutic Area Specialist, Cardiovascular Community, CV Brooklyn, NY at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Field-based role requiring 100% time spent with external customers in Brooklyn, NY territory
High level of scientific expertise in assigned products and cardiovascular therapeutic area
Strong professional credibility with regional thought leaders (RTLs), community-based physicians/HCPs in private practice, medical groups, office staff, and other stakeholders
Ability to engage HCPs with differentiated Customer Experience (Cx) through deeper scientific dialogue consistent with label
Proficiency in using tools like CE^3 to derive insights and inform call plans
Capability to liaise with other BMS functions to deliver higher Customer Experience

Responsibilities

Promote approved indications of BMS products within defined territory/region to meet or exceed sales targets in compliant manner
Create demand for BMS medicines by articulating balanced clinical and scientific rationale for use in appropriate patients
Engage with and maintain/grow scientific expertise in all assigned products and therapeutic areas
Prepare and implement comprehensive territory and account plans
Proactively use tools like CE^3 to derive insights, dynamically inform call plans, and provide feedback to leadership
Demonstrate scientific expertise and passion in fair & balanced scientific dialogue using approved resources
Drive adoption of new and existing medicines for appropriate patients through impactful engagement with HCPs
Prioritize safe and appropriate use of BMS products while focusing on business results, performance objectives, and BMS values

Skills

Cardiovascular

Pharmaceutical Sales

HCP Engagement

Therapeutic Area Expertise

BioPharma

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free